Back to School: How biopharma can reboot drug development. Access exclusive analysis here
CoTherix (South San Francisco, Calif.) postponed its proposed IPO, citing market conditions.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury